Penumbra Inc. , which designs and markets devices for the treatment of strokes and other vascular conditions, priced its initial public offering at $30 a share, according to Renaissance Capital. The company sold 4 million shares, valuing it at about $1 billion. The IPO had been expected to price in a range between $25 a share to $28 a share. The Alameda, Calif., company plans to list on the New York Stock Exchange under the ticker symbol PEN.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
From:: Stock Market News